Tuesday 2/13 | 5-7:30 PM | Polsinelli 1401 Lawrence St.
AQ BioMed has developed an aqueous shunt used to prevent blindness due to over-pressurization in the $3B glaucoma market. The company was recently awarded a Colorado Advanced Industries grant and is currently raising mating funds to bring the device that has over 20 years of R&D, 5 issued and 2 pending patents, to market. The average selling price for the device will be $775 in and is reimbursed in the US. Cost of goods is less than $20. AQ BioMed believes it can enter the $100M+ glaucoma shunt market and achieve over $15M in sales in the next 3 to 5 years. aqbiomed.com.
MFB Fertility is an early-stage medical device company focused on women’s health. Our expertise is developing innovative immunoassay test systems that will revolutionize the way infertility is diagnosed and treated. 1 in 8 couples struggle to conceive or carry a baby to term, but only 1⁄4 of them have access to care. Our innovative products will increase access to care and grow the now 2 billion dollar market. mfbfertility.com
PharmaJet has developed user-friendly, inexpensive device platforms for fluid injection into the body without a needle. Able to compete with traditional needle-syringe delivery, which inherently poses costly needle-stick, re-use and pass-along disease issues, PharmaJet’s devices have been optimized for vaccine administration, a 2.8B annual immunization market growing in excess of the 140m annual birth cohort. Unique in the field of jet injection because of its ability to reach target tissues accurately and comfortably, PharmaJet has unique scientific claims and wide regulatory clearances. pharmajet.com
PrecisionProfile is focused on enabling the precision medicine community to “make sense” of genomic profiles to create personalized treatment plans for patients. The University of Colorado Cancer Center has developed a genomic analytics platform and a “patients like mine” cohort analytics approach, and PrecisionProfile has been formed as an Anschutz Medical Campus spinoff to create a product to advance the practice of cancer precision medicine. precisionprofile.com